September 12, 2025 FDA Considers Ending Routine Advisory Committees on New Drugs The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency. KFF Health News
September 02, 2025 AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
September 02, 2025 Pathology Machine-Learning Models and Diagnosis of Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
April 30, 2025 AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash The ASCO Post
September 02, 2025 Dual Immunotherapy May Improve Progression-Free Survival in Advanced Squamous Cell Carcinoma The ASCO Post
September 02, 2025 Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
September 02, 2025 Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
August 22, 2025 Perceived Dermatologic Side Effects of Cancer Treatment: Pilot Survey Findings The ASCO Post
April 26, 2024 New Social Media Trend Involving Freckle Tattoos May Conceal Early Signs of Skin Cancer Conexiant
April 29, 2024 Exposed to Agent Orange at US Bases, Veterans Face Cancer Without VA Compensation KFF Health News